113 related articles for article (PubMed ID: 3159074)
1. Immune phenotype heterogeneity in AML.
Ost A; Christensson B; Andreasen R; Hast R; Lagerlöf B; Reizenstein P; Trowbridge IS; Biberfeld P
Scand J Haematol; 1985 Apr; 34(4):293-302. PubMed ID: 3159074
[TBL] [Abstract][Full Text] [Related]
2. Expression of the three myeloid cell-associated immunoglobulin G Fc receptors defined by murine monoclonal antibodies on normal bone marrow and acute leukemia cells.
Ball ED; McDermott J; Griffin JD; Davey FR; Davis R; Bloomfield CD
Blood; 1989 May; 73(7):1951-6. PubMed ID: 2469504
[TBL] [Abstract][Full Text] [Related]
3. Surface marker analysis in acute myeloid leukaemia and correlation with FAB classification.
San Miguel JF; Gonzalez M; Cañizo MC; Anta JP; Zola H; Lopez Borrasca A
Br J Haematol; 1986 Nov; 64(3):547-60. PubMed ID: 3466644
[TBL] [Abstract][Full Text] [Related]
4. Antigenic phenotype of the myeloid leukaemic cells defined by monoclonal antibodies.
Robak T; Korycka A
Arch Immunol Ther Exp (Warsz); 1987; 35(1):33-42. PubMed ID: 3477133
[TBL] [Abstract][Full Text] [Related]
5. Correlation of morphological FAB classification and immunophenotyping: value in recognition of morphological, cytochemical and immunological characteristics of mixed leukaemias.
Boban D; Sucić M; Marković-Glamocak M; Uzarević B; Batinić D; Marusić M; Nemet D; Labar B; Hitrec V
Eur J Cancer; 1993; 29A(8):1167-72. PubMed ID: 8518029
[TBL] [Abstract][Full Text] [Related]
6. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
[TBL] [Abstract][Full Text] [Related]
7. Staging of leukemic progenitor cells in acute myeloid leukemia by phenotyping with myeloid monoclonal antibodies.
Hast R; Dowding C; Robak T; Goldman JM
Exp Hematol; 1986 Nov; 14(10):981-7. PubMed ID: 3464449
[TBL] [Abstract][Full Text] [Related]
8. Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia.
Griffin JD; Davis R; Nelson DA; Davey FR; Mayer RJ; Schiffer C; McIntyre OR; Bloomfield CD
Blood; 1986 Dec; 68(6):1232-41. PubMed ID: 2946331
[TBL] [Abstract][Full Text] [Related]
9. Morphologic immunophenotypic and cytogenetic patterns of adult acute myeloid leukemia in Saudi Arabia.
Roberts GT; Spence DG; Padmos MA; Sheth KV; Clink H; Ernst P
Leuk Res; 1992; 16(2):181-90. PubMed ID: 1545571
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotype of clonogenic cells in myeloid leukaemia.
Kabral A; Bradstock KF; Grimsley P; Favaloro EJ
Leuk Res; 1988; 12(1):51-9. PubMed ID: 3162752
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic significance of myelomonocytic cell surface antigens in acute myeloid leukaemia.
Merle-Beral H; Nguyen Cong Duc L; Leblond V; Boucheix C; Michel A; Chastang C; Debre P
Br J Haematol; 1989 Nov; 73(3):323-30. PubMed ID: 2605121
[TBL] [Abstract][Full Text] [Related]
12. Discrepancies between morphologic, cytochemical, and immunologic characteristics in acute myeloblastic leukemia.
del Canizo MC; San Miguel JF; Gonzalez M; Anta JP; Orfao A; Lopez-Borrasca A
Am J Clin Pathol; 1987 Jul; 88(1):38-42. PubMed ID: 3474879
[TBL] [Abstract][Full Text] [Related]
13. Coexpression of p165 myeloid surface antigen and terminal deoxynucleotidyl transferase: a comparison of acute myeloid leukaemia and normal bone marrow cells.
Bradstock KF; Kerr A; Kabral A; Favaloro EJ; Hewson JW
Am J Hematol; 1986 Sep; 23(1):43-50. PubMed ID: 3526873
[TBL] [Abstract][Full Text] [Related]
14. Human myeloid differentiation antigens identified by monoclonal antibodies: expression on leukemic cells.
Bradstock KF; Favaloro EJ; Kabral A; Kerr A; Hughes WG; Berndt MC; Musgrove E
Pathology; 1985 Jul; 17(3):392-9. PubMed ID: 3865147
[TBL] [Abstract][Full Text] [Related]
15. Correlation of surface marker expression with morphologically and immunologically defined subclasses of acute myeloid leukaemias.
Drexler HG; Menon M; Klein M; Bhoopalam N; Messmore HL; Minowada J
Clin Exp Immunol; 1986 Aug; 65(2):363-72. PubMed ID: 3466728
[TBL] [Abstract][Full Text] [Related]
16. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
[TBL] [Abstract][Full Text] [Related]
17. Leukaemia cell mobility in childhood acute myeloid leukaemia based on the FAB classification.
Yamazaki M; Komiyama A; Yamazaki T; Yasui K; Morohashi F; Miyagawa Y; Akabane T
Scand J Haematol; 1985 Nov; 35(5):481-6. PubMed ID: 3867130
[TBL] [Abstract][Full Text] [Related]
18. Immunological markers in acute leukaemia.
Avnstrøm S; Ralfkier E; Clausen N; Plesner T; Hansen NE; Nissen NI
Scand J Haematol; 1985 Jan; 34(1):16-21. PubMed ID: 3918339
[TBL] [Abstract][Full Text] [Related]
19. Expression of myeloid differentiation antigens on myeloblasts in bone marrow of patients with myelodysplastic syndromes.
Borbenyi Z; Ghosh A; Cinkotai K; Balogh E; Moore M
Biomed Pharmacother; 1987; 41(2):101-4. PubMed ID: 3475134
[TBL] [Abstract][Full Text] [Related]
20. Specificity and diagnostic implications of the reactivity pattern of a panel of monoclonal antibodies against myeloid leukemia cells.
Andreasen RB; Biberfeld P; Ost A; Reizenstein P; Olsson L
Scand J Haematol; 1986 Oct; 37(4):323-32. PubMed ID: 2431458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
